Mon, April 8, 2024
Fri, April 5, 2024
Thu, April 4, 2024
Wed, April 3, 2024
Tue, April 2, 2024

Carter Gould Maintained (BIIB) at Hold with Decreased Target to $215 on, Apr 4th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-215-on-apr-4th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Carter Gould of Barclays, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $230 to $215 on, Apr 4th, 2024.

Carter has made no other calls on BIIB in the last 4 months.



There are 15 other peers that have a rating on BIIB. Out of the 15 peers that are also analyzing BIIB, 2 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $250 on, Friday, February 16th, 2024
  • Mohit Bansal of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $240 on, Wednesday, February 14th, 2024


These are the ratings of the 13 analyists that currently disagree with Carter


  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $340 on, Monday, March 25th, 2024
  • Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $364 on, Tuesday, March 5th, 2024
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $277 on, Thursday, February 22nd, 2024
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $305 on, Tuesday, February 20th, 2024
  • Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $311 on, Tuesday, February 20th, 2024
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $285 on, Wednesday, February 14th, 2024
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $290 on, Wednesday, February 14th, 2024
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $316 on, Wednesday, February 14th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $325 on, Wednesday, February 14th, 2024
  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $300 on, Wednesday, February 14th, 2024
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Wednesday, February 14th, 2024
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $287 on, Thursday, December 14th, 2023
  • Danielle Brill of "Raymond James" Upgraded from Hold to Buy and Held Target at $283 on, Thursday, December 7th, 2023

Publication Contributing Sources